Russell Frank Company’s Filana Therapeutics FLNA Stock Holding History

Russell Frank Company’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,113	Closed	-$16K	–	3023
2014 Q4	$16K	Sell	1,113 -874	-44%	-$15.1K	﹤0.01%	2891
2014 Q3	$54K	Hold	1,987	–	–	﹤0.01%	2723
2014 Q2	$57K	Buy	+1,987	New	+$73.5K	﹤0.01%	2694
2013 Q4	–	Sell	-8	Closed	–	–	3007
2013 Q3	$0	Sell	8 -33	-80%	-$577	﹤0.01%	3482
2013 Q2	$1K	Buy	+41	New	+$867	﹤0.01%	3253

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Russell Frank Company's FLNA Position: Q1 2015 in Review

Russell Frank Company sold out of Filana Therapeutics (FLNA) in Q1 2015, closing a stake of 1,113 shares — an estimated $16K sold.

Russell Frank Company first reported a position in FLNA in Q2 2013 and held it in 5 quarters. The position peaked at $57K in Q2 2014. 64 funds tracked by Wall St. Rank hold FLNA as of Q1 2015.

Russell Frank Company reported no remaining Filana Therapeutics position as of Q1 2015 after selling out during the quarter.
Russell Frank Company sold 1,113 Filana Therapeutics shares in Q1 2015, an estimated $16K.
Russell Frank Company first reported a position in Filana Therapeutics in Q2 2013 and held it in 5 quarters.
Russell Frank Company's Filana Therapeutics position peaked at $57K in Q2 2014.
64 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2015.

Based on Russell Frank Company's 13F filing for Q1 2015, filed 13 May 2015.